N-Heterocyclic carbene-silver complexes:: A new class of antibiotics

被引:441
作者
Kascatan-Nebioglu, Aysegul
Panzner, Matthew J.
Tessier, Claire A.
Cannon, Carolyn L.
Youngs, Wiley J. [1 ]
机构
[1] Univ Akron, Dept Chem, Akron, OH 44325 USA
[2] Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA
基金
美国国家科学基金会;
关键词
N-heterocyclic carbene; silver; antimicrobial; encapsulation; caffeine; cystic fibrosis;
D O I
10.1016/j.ccr.2006.08.019
中图分类号
O61 [无机化学];
学科分类号
070301 ; 081704 ;
摘要
N-Heterocyclic carbene (NHC)-silver complexes were synthesized from pyridine linked pincer ligands and methylated caffeine. Pincer NHC-silver complexes were found to have more potent antimicrobial activity than the conventionally used silver antimicrobials. Encapsulation of a gem-diol pincer NHC-silver complex in a polymer mat demonstrated a promising method for the sustained delivery of silver ions in wound care applications. An NHC precursor derived from caffeine was found to have a low toxicity and the resulting silver complex showed encouraging antimicrobial activity against numerous pathogens including resistant organisms isolated from the lungs of patients with cystic fibrosis (CF). Bacteria studied included members of the Burkholderia cepacia complex, which cause significant morbidity and mortality in infected CF patients. This review explores this newly growing area, focusing on the synthesis from pincer and xanthine ligands of new silver-NHC complexes and their antimicrobial activities. (c) 2006 Elsevier B.V. All rights reserved.
引用
收藏
页码:884 / 895
页数:12
相关论文
共 94 条
[1]   A highly stable N-heterocyclic carbene complex of trichloro-oxo-vanadium(V) displaying novel Cl-Ccarbene bonding interactions [J].
Abernethy, CD ;
Codd, GM ;
Spicer, MD ;
Taylor, MK .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2003, 125 (05) :1128-1129
[2]   An in vitro assessment of the antibacterial properties and cytotoxicity of nanoparticulate silver bone cement [J].
Alt, V ;
Bechert, T ;
Steinrücke, P ;
Wagener, M ;
Seidel, P ;
Dingeldein, E ;
Domann, E ;
Schnettler, R .
BIOMATERIALS, 2004, 25 (18) :4383-4391
[3]   Determination of minimum inhibitory concentrations [J].
Andrews, JM .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2001, 48 :5-16
[4]  
[Anonymous], 2005, BR J NURS, DOI DOI 10.12968/BJ0N.2005.14.SUP5.19954
[5]   A STABLE CRYSTALLINE CARBENE [J].
ARDUENGO, AJ ;
HARLOW, RL ;
KLINE, M .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1991, 113 (01) :361-363
[6]   HOMOLEPTIC CARBENE SILVER(I) AND CARBENE COPPER(I) COMPLEXES [J].
ARDUENGO, AJ ;
DIAS, HVR ;
CALABRESE, JC ;
DAVIDSON, F .
ORGANOMETALLICS, 1993, 12 (09) :3405-3409
[7]  
Atiyeh Bishara S., 2002, Current Pharmaceutical Biotechnology, V3, P179, DOI 10.2174/1389201023378283
[8]   CRYSTAL-STRUCTURE OF 2-SULFANILAMIDOPYRIMIDINESILVER(I) [J].
BAENZIGER, NC ;
STRUSS, AW .
INORGANIC CHEMISTRY, 1976, 15 (08) :1807-1809
[9]   NEW TRANSITION-METAL COMPLEXES WITH NUCLEIC-ACID BASES AND NUCLEOSIDES [J].
BECK, W ;
KOTTMAIR, N .
CHEMISCHE BERICHTE-RECUEIL, 1976, 109 (03) :970-993
[10]   Drug diffusion through cystic fibrotic mucus: Steady-state permeation, rheologic properties, and glycoprotein morphology [J].
Bhat, PG ;
Flanagan, DR ;
Donovan, MD .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1996, 85 (06) :624-630